Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Durata Therapeutics is Profiled in this Database

Updated At 27 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
Long-acting, intravenous lipoglycopeptide used to treat acute bacterial skin and skin structure infections

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Durata Therapeutics plus 4982 other startups.

Start Free 7 Day Trial Now

Learn More About Durata Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients